Trexquant Investment LP Olink Holding Ab (Publ) Transaction History

Trexquant Investment LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$21.81 - $25.14 $576,721 - $664,777	26,443 New	26,443 $621,000
Q3 2023 Nov 13, 2023	BUY	$14.45 - $20.34 $89,488 - $125,965	6,193 Added 22.97%	33,156 $489,000
Q2 2023 Aug 11, 2023	BUY	$17.13 - $23.74 $246,809 - $342,045	14,408 Added 114.76%	26,963 $505,000
Q1 2023 May 15, 2023	SELL	$19.34 - $24.11 $154,062 - $192,060	-7,966 Reduced 38.82%	12,555 $282,000
Q4 2022 Feb 13, 2023	BUY	$12.64 - $25.52 $106,125 - $214,265	8,396 Added 69.25%	20,521 $520,000
Q3 2022 Nov 14, 2022	SELL	$12.14 - $18.42 $334,372 - $507,342	-27,543 Reduced 69.43%	12,125 $147,000
Q2 2022 Aug 11, 2022	BUY	$8.95 - $19.24 $66,131 - $142,164	7,389 Added 22.89%	39,668 $603,000
Q1 2022 May 13, 2022	BUY	$11.33 - $19.3 $365,721 - $622,984	32,279 New	32,279 $570,000

799K

Ticker OLK
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 119,098,000
Description
Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.